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1. Introduction 
Hepatocytes differ from other secretory cells in 
that they secrete materials into two separate fluids, 
the blood and bile. Serum proteins and glycoproteins 
are obviously discharged at the sinusoidal surface of 
hepatocytes [ 11, but the route by which proteins 
enter bile is less evident. Although many of the pro- 
teins present in rat bile are also to be found in rat 
serum, the relative concentrations of the different 
proteins are markedly different in the two fluids [2]. 
In addition to ‘serum’ proteins, bile contains the 
secretory component of IgA which is not found in 
blood [2,3] together with small amounts of hepato- 
cyte plasma membrane proteins. There must, it 
appears, be some mechanism which sorts proteins 
destined for bile from proteins destined for blood. 
Recent experiments have suggested a simple mech- 
anism for routing at least some of the major proteins 
into bile without an elaborate system of sorting 
secretory granules. IgA is carried rapidly from serum 
to bile [4,.5]. The IgA binds to a receptor on the 
sinusoidal surface of hepatocytes [6] and is taken up 
into specialised endocytic vesicles [7] which discharge 
their contents into bile. The receptor is probably 
secretory component ([8], E.Orlans, J. Peppard, J. R. 
Fry,R.H.H.and B. M. M., unpublished experiments). 
This system immediately accounts for the presence of 
IgA in bile and, if excess secretory component were 
present in the vesicles, would also account for the 
presence of the free secretory component. If, as seems 
likely, these or similar vesicles carry other proteins 
across hepatocytes, one can postulate that all ‘export’ 
proteins made in hepatocytes are transferred to the 
sinusoidal face of the cell but that some proteins are 
then transferred across to the bile canalicular face in 
association with endocytic vesicles. At the bile- 
canalicular face such vesicle-associated proteins are 
released, together with small amounts of typical 
plasma membrane proteins, probably by the detergent 
action of bile salts [9]. 
If bile proteins travel initially to the sinusoidal 
surface of the hepatocyte and then have to travel 
back across the cell, one would expect that newly 
synthesised proteins would appear in serum first and 
would appear in bile only after a lag phase represent- 
ing the time taken to recross the cell. We have, there- 
fore, studied the release of newly synthesised glyco- 
proteins, labelled by L- [ 1 -14C] fucose and monitored 
their appearance in serum and bile. All the major 
proteins of rat bile except albumin have bound 
carbohydrate groups [2]. Fucose is incorporated into 
glycoproteinsimmediately before their discharge from 
liver [IO] so that labelling with fucose, rather than an 
amino acid, avoids uncertainties over the rates of 
processing of different proteins in the endoplasmic 
reticulum and Golgi apparatus. We find the expected 
lag phase in the appearance of newly synthesized 
glycoproteins in bile. 
2. Material and methods 
Hooded rats of the University of Surrey strain 
were used in all experiments. The rats were maintained 
under pentobarbital (Sagatal, May and Baker, 
Dagenham, Kent) anaesthesia throughout the experi- 
ment. The common bile duct was cannulated and the 
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body wall and skin ligatured to avoid dehydration. 
G[ l-‘4C]fucose (0.2-3 ml) (50 #Zifml, purchased 
from the ~diochemic~ centre, Hershey was 
injected into the femoral vein. Bile was collected for 
1.5 min periods. Blood samples (-20 ~1) were collected 
from the tip of the tail. The samples were diluted with 
-80 ~1 of 0.15 M NaCl/S mM EDTA pH 7.4 and the 
red blood cells removed by centrifugation. 
Acid-precipitable proteins in serum and bile were 
assayed by the method in [ 111. The method was 
modified in that the initial precipitate was collected 
by centrifugation to permit sampling of the super- 
natant. The pellet was resuspended, transferred to a 
GF-B glass fibre filter ~a~~ Lab. Sales Ltd, 
Maidstone, Kent) and thereafter processed according 
to the original scheme. The distribution of label 
among the different glycoproteins present in serum 
and bile was determined by crossed immunoelectro- 
phoresis [121 against antijrat serum) (Mercia 
Brocades Ltd, West Bytleet, Surrey) or an antiserum 
prepared against rat bile using the dosage schedule 
given in [13]. 
3. Results 
In these experiments we examined the appearance 
of acid-precipitable 14C-labelled glycoproteins in 
plasma nd in bile fo~ow~g the intravenous injection 
of [‘4C]fucose into rats. In plasma, acid-soluble 
fucose disappeared very rapidly and *4C-labelled 
glycoproteins accumulated progessively over the 2 h 
period of study (fig-la) with no apparent lag phase. 
The rate of accumulation of “C-labelled glycoproteins 
in plasma does, however, slowly decrease, due, 
probably, to the dilution of the pool of [‘4C]fucose 
in liver. These results are consistent with those 
obtained in [IO]. 
The kinetics of appearance of “C-labelled glyco- 
proteins in bile (fig.1 b) were markedly different from 
those of 14C-labe~ed glycoprote~s in plasma. There 
was a marked lag phase; only small amounts of 
labelled glycoproteins appeared in bile during the 
first 30 min after injection of [r4C]fucose. The amount 
of “Clabelled glycoproteins in bile then increased 
rapidly up to -70 min following injection of the 
fucose and then slowly declined. 
In order to determine which proteins are labelled 
by [‘4C]gucose, we fractionated plasma nd bile pro- 
teins by crossed immunoelectrophoresis using auto- 
radiography to determine which proteins had incor- 
porated the [r4C]fucose. The results (fig.2) showed 
that all but one of the major bile proteins were 
labelled by [14C]fucose. The non-radioactive protein 
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Fig.1. Appearance of acid-precipitable “‘C-labelled glycoproteins in (a) plasma and (b) bile following intravenous injection of 
L-[ I-‘*C]fucose into rats. The results from 3 different animals are presented separately. The results are presented as cpm/ml fluid 
in the case of rats 1 and 3 (*,A) and cpm/O.S ml fluid in the case of rat 2 (=) which received a larger dose of fucose. 
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Fig.2. Pattern obtained after crossed immunoefec~ophore~s 
of rat bile collected between 4.5 min and 60 mm after 
intravenous injection of L-[ 1-‘4C]fucose. Electrophoresis 
was against an anti-(rat bile) antiserum. The plate was stained 
for protein using Coomassie brilliant blue R (a) and glyco- 
proteins containing f Y]fucose were located by autoradiog- 
raphy (b). The proteins are numbered as in [ 21. The arrows 
at the base of the figures show the direction of electro- 
pho~sis in the fist Trenton. 
‘1’ is undoubtedly albumin, The autoradiographic 
studies make clear that the [14C]fucose isprincipally 
incorporated into the three major bile proteins 
labelled ‘D’, ‘8’ and ‘11’ in fig.2 From 121 we can 
identify these as free IgA, secretory component, a
glycoprotein of unknown function, and secretory IgA, 
respectively. The fucose label associated with the 
secretory IgA is most probably due to the bound 
secretory component. There is also some fucose label 
associated with the minor bile protein ‘5’ which our 
earlier esults [Z] suggest isidentical to a major serum 
glycoprotein. Electrophoresis of bile against anti- 
(rat serum),,showed that the specific activity of this 
protein in bile was at least as high as the specific 
activity of the homologous protein in serum. In plasma 
the label seemed un~ormly spread among the different 
glycoproteins. 
4. Discussion 
Our results how that there is, indeed, the lag phase 
in the appearance of newly made,glycoproteins  bile 
which, as mentioned in section 1, would occur if 
newly made biliary glycoproteins are carried first to 
the sinusoidal surface of the cell and then back across 
the cell into bile. The time course is very similar to the 
time course of IgA transport; intravenously injected 
IgA binds almost instantaneously to the sinusoidal 
surface of hepatocytes [6] but there is a lag of 
-30 min before IgA appears in bile [4]. The similarity 
in the time for newly made glycoproteins to appear 
in bile and the time taken for IgA to be tr~sported 
across the hepatocyte, together with the known asso- 
ciation of secretory component and bile protein 8 with 
the ‘shuttle’ vesicles [7,14] strongly suggests hat the 
‘shuttle’vesicles not only transport IgA from blood to 
bile, but also convey newly made free secretory com- 
ponent and at least one other major bile protein. 
The formation of secretory component and bile 
protein 8 represents a significant metabolic effort for 
the hepatocyte. The amount of glycoprotein appearing 
in bile at 30-60 min averages 5 15 cpm/min (the bile 
flow in our rats is -_I ml/h). The blood volume of our 
rats is -12 ml, hence we would calculate that the rate 
of discharge of newly made glycoproteins in the first 
30 min of labellmg as -67 000 cpm/min. It must, 
however, be remembered that the label in serum is 
divided among many glycoproteins while the label in 
bile is essentially confmed to two. The reasons for 
this investment of metabolic energy are not yet clear. 
Secretory component is, apparently, the receptor for 
IgA [8]. The function of bile protein 8 is not clear 
but some circumstantial evidence suggests hat it may 
also have a transport function, possibly carrying small 
molecules. It would seem, then, that althou~ leakage 
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of major serum proteins across tight junctions [IS] 
may supply some minor bile proteins whilst others 
may be dissolved from the canalicular plasma mem- 
brane [9], those major bile proteins which have a 
high bile/blood concentration ratio are supplied via 
the endocytic vesicle shuttle. 
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